Katerina Mardilovich

Katerina Mardilovich is an accomplished expert in T-cell process development with extensive experience at Adaptimmune, where roles include Associate Director for Autologous and Allogeneic T-cell Process and Analytical Development, Group Leader, and Principal Scientist. Prior experience includes post-doctoral research at Cancer Research UK Beatson Institute, focusing on inflammation's role in lymphoma development and drug target validation in cancer cell lines. Educational credentials encompass a Ph.D. in Biomedical Sciences with a specialization in Cancer Research from UMass Chan Medical School and a BS in Biotechnology from Worcester Polytechnic Institute. Katerina has demonstrated a strong commitment to mentorship and research innovation throughout a career dedicated to advancing cancer therapies.